MedTrace Logo

Diagnosis of PCL With EUS-FNA and Cross-sectional Imaging - A Report of Accuracy

NCT03884179 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 58

Last updated 2019-03-21

No results posted yet for this study

Summary

Pancreatic cystic lesions (PCLs) comprise of a heterogeneous group of entities that are benign, premalignant or malignant. With increased use of modern imaging techniques in recent years, incidentally discovered PCL have become much more common. However, imaging modalities for characterising PCL is a known clinical uncertainty since imaging is capable of detecting these lesions but may often not be able to distinguish malignant from benign lesions. Incorrect assessment of PCL can lead to fatal consequences because a malignant lesion may not be treated and a benign may be unnecessarily resected. The aim of this study was to assess the performance of endoscopic ultrasound with fine-needle aspiration (EUS-FNA) in the diagnosis of pancreatic cystic lesions compared to cross-sectional imaging modalities (CT/MRI). Our hypothesis is that EUS-FNA has a higher accuracy for diagnosing PCLs compared with cross-sectional imaging.

Conditions

  • Pancreatic Cyst
  • Pancreatic Neuroendocrine Carcinoma
  • Pancreatic Pseudocyst
  • Pancreatic Serous Cystadenoma
  • Pancreatic Mucinous Cystadenoma
  • Pancreatic Cystadenocarcinoma
  • Pancreatic Intraductal Papillary-Mucinous Neoplasm
  • Solid Pseudopapillary Tumor of the Pancreas

Sponsors & Collaborators

  • Sahlgrenska University Hospital

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-02-01
Primary Completion
2017-12-01
Completion
2020-03-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03884179 on ClinicalTrials.gov